EPIRUS BIOPHARMACEUTICALS IN's ticker is EPRSQ and the CUSIP is 29428P107. A total of 24 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TPG Group Holdings (SBS) Advisors, Inc. | 2,223,922 | $12,610,000 | 0.08% |
| Cormorant Asset Management, LP | 75,000 | $425,000 | 0.07% |
| Spark Investment Management LLC | 17,600 | $98,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 522,007 | $2,960,000 | 0.01% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 10,116 | $57,000 | 0.00% |
| MORGAN STANLEY | 3,783 | $22,000 | 0.00% |
| SIMPLEX TRADING, LLC | 110 | $1,000 | 0.00% |
| NATIONAL PLANNING CORP | 101 | $590,000 | 0.00% |
| American Research & Management Co. | 25 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 147 | $1,000 | 0.00% |